Jun Ishihara

2.0k total citations
38 papers, 1.4k citations indexed

About

Jun Ishihara is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jun Ishihara has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jun Ishihara's work include Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jun Ishihara is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), CAR-T cell therapy research (12 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Jun Ishihara collaborates with scholars based in United States, United Kingdom and Japan. Jun Ishihara's co-authors include Jeffrey A. Hubbell, Ako Ishihara, Kazuto Fukunaga, Melody A. Swartz, Aslan Mansurov, Peyman Hosseinchi, Koichi Sasaki, Lambert Potin, John‐Michael Williford and Michael White and has published in prestigious journals such as Nature Communications, Blood and Biomaterials.

In The Last Decade

Jun Ishihara

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Ishihara United States 19 574 523 414 299 202 38 1.4k
Douglas P. Dyer United Kingdom 17 497 0.9× 403 0.8× 438 1.1× 102 0.3× 44 0.2× 29 1.3k
Sarah A. Lewin United States 16 866 1.5× 528 1.0× 586 1.4× 833 2.8× 490 2.4× 18 2.0k
Ayad Eddaoudi United Kingdom 19 865 1.5× 389 0.7× 606 1.5× 179 0.6× 84 0.4× 31 2.0k
Thomas Hieronymus Germany 27 1.2k 2.0× 299 0.6× 660 1.6× 119 0.4× 103 0.5× 47 2.1k
Ji Min Oh South Korea 21 399 0.7× 255 0.5× 1.4k 3.5× 360 1.2× 147 0.7× 50 2.1k
Joseph J. Skitzki United States 22 752 1.3× 928 1.8× 461 1.1× 254 0.8× 77 0.4× 74 1.9k
Laura F. Gibson United States 25 373 0.6× 479 0.9× 989 2.4× 268 0.9× 98 0.5× 70 2.6k
Mirela Anghelina United States 18 294 0.5× 239 0.5× 562 1.4× 87 0.3× 59 0.3× 41 1.3k
Shiro Mori Japan 31 452 0.8× 785 1.5× 626 1.5× 735 2.5× 154 0.8× 123 2.6k
Juan Carlos Varela United States 21 496 0.9× 357 0.7× 287 0.7× 109 0.4× 43 0.2× 63 1.1k

Countries citing papers authored by Jun Ishihara

Since Specialization
Citations

This map shows the geographic impact of Jun Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ishihara more than expected).

Fields of papers citing papers by Jun Ishihara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ishihara. The network helps show where Jun Ishihara may publish in the future.

Co-authorship network of co-authors of Jun Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ishihara. A scholar is included among the top collaborators of Jun Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ishihara. Jun Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sasaki, Koichi, Vipul Bhatia, Chuyi Wang, et al.. (2025). Collagen-binding IL-12-armoured STEAP1 CAR-T cells reduce toxicity and treat prostate cancer in mouse models. Nature Biomedical Engineering.
2.
Murad, John P., Yuwei Ren, Anthony K. Park, et al.. (2025). Solid tumour CAR-T cells engineered with fusion proteins targeting PD-L1 for localized IL-12 delivery. Nature Biomedical Engineering. 2 indexed citations
3.
Alpar, Aaron T., Ako Ishihara, Aslan Mansurov, et al.. (2023). Topically-applied collagen-binding serum albumin-fused interleukin-4 modulates wound microenvironment in non-healing wounds. npj Regenerative Medicine. 8(1). 49–49. 6 indexed citations
4.
Cunningham, Brian C., et al.. (2023). Capillary‐Scale Hydrogel Microchannel Networks by Wire Templating. Small. 19(42). e2301163–e2301163. 12 indexed citations
5.
Mansurov, Aslan, Lisa R. Volpatti, Kevin Chang, et al.. (2023). Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicity. Science Advances. 9(48). eadh9879–eadh9879. 17 indexed citations
6.
Ishihara, Jun, et al.. (2023). The clinical terrain of immunotherapies in heterogeneous pancreatic cancer: unravelling challenges and opportunities. The Journal of Pathology. 260(5). 533–550. 6 indexed citations
7.
Tzeng, Stephany Y., et al.. (2023). An engineered immunocytokine with collagen affinity improves the tumor bioavailability, tolerability, and therapeutic efficacy of IL-2. Cell Reports Medicine. 4(11). 101289–101289. 6 indexed citations
8.
Sasaki, Koichi, et al.. (2022). Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy. Journal of Materials Chemistry B. 10(37). 7491–7511. 17 indexed citations
9.
Mansurov, Aslan, Peyman Hosseinchi, Kevin Chang, et al.. (2022). Masking the immunotoxicity of interleukin-12 by fusing it with a domain of its receptor via a tumour-protease-cleavable linker. Nature Biomedical Engineering. 6(7). 819–829. 63 indexed citations
10.
Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 5(5). 387–398. 31 indexed citations
11.
Mansurov, Aslan, Jun Ishihara, Peyman Hosseinchi, et al.. (2020). Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nature Biomedical Engineering. 4(5). 531–543. 178 indexed citations
12.
Ishihara, Ako, Jun Ishihara, Elyse A. Watkins, et al.. (2020). Publisher Correction: Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nature Biomedical Engineering. 4(11). 1117–1117. 2 indexed citations
13.
Ishihara, Jun, Ako Ishihara, Koichi Sasaki, et al.. (2019). Targeted antibody and cytokine cancer immunotherapies through collagen affinity. Science Translational Medicine. 11(487). 147 indexed citations
14.
Ishihara, Jun, Ako Ishihara, Richard Starke, et al.. (2019). The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood. 133(24). 2559–2569. 88 indexed citations
15.
Williford, John‐Michael, Jun Ishihara, Ako Ishihara, et al.. (2019). Recruitment of CD103 + dendritic cells via tumor-targeted chemokine delivery enhances efficacy of checkpoint inhibitor immunotherapy. Science Advances. 5(12). eaay1357–eaay1357. 99 indexed citations
16.
Sasaki, Koichi, Jun Ishihara, Ako Ishihara, et al.. (2019). Engineered collagen-binding serum albumin as a drug conjugate carrier for cancer therapy. Science Advances. 5(8). eaaw6081–eaaw6081. 69 indexed citations
17.
Ishihara, Jun, Lambert Potin, Peyman Hosseinchi, et al.. (2018). Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity. Molecular Cancer Therapeutics. 17(11). 2399–2411. 36 indexed citations
18.
Ishihara, Jun, Ako Ishihara, Kazuto Fukunaga, et al.. (2018). Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing. Nature Communications. 9(1). 2163–2163. 186 indexed citations
19.
Ishihara, Jun, Kazuto Fukunaga, Ako Ishihara, et al.. (2017). Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events. Science Translational Medicine. 9(415). 135 indexed citations
20.
Iwata, Takanori, et al.. (2014). A role for c-Kit in the maintenance of undifferentiated human mesenchymal stromal cells. Biomaterials. 35(11). 3618–3626. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Douglas P. Dyer Breakdown of academic impact, for papers by Sarah A. Lewin Breakdown of academic impact, for papers by Ayad Eddaoudi Breakdown of academic impact, for papers by Thomas Hieronymus Breakdown of academic impact, for papers by Ji Min Oh Breakdown of academic impact, for papers by Joseph J. Skitzki Breakdown of academic impact, for papers by Laura F. Gibson Breakdown of academic impact, for papers by Mirela Anghelina Breakdown of academic impact, for papers by Shiro Mori Breakdown of academic impact, for papers by Juan Carlos Varela
Rankless by CCL
2026